RxSight (RXST)
(Real Time Quote from BATS)
$47.43 USD
+0.66 (1.41%)
Updated Jul 22, 2024 03:05 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Price, Consensus and EPS Surprise
RXST 47.43 +0.66(1.41%)
Will RXST be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RXST based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RXST
RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?
RXST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buy 5 Medical Instruments Stocks to Enhance Your Portfolio
Is First Trust Small Cap Growth AlphaDEX ETF (FYC) a Strong ETF Right Now?
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
Other News for RXST
Small-cap, buy-rated stocks with positive estimate revision factors - BofA
Insider Sale: Director Julie Andrews Sells 15,625 Shares of RxSight Inc (RXST)
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
What's Driving Establishment Labs Holdings Inc's Surprising 19% Stock Rally?
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to its Board of Directors and Scientific Advisory Board